Zeng Huabei, Xia Chunhua, Cheng Zhiyong, Shan Yidong, Zhang Yu, Zhang Zhongjun
Wuxi Medical College, Jiangnan University Wuxi 214122, Jiangsu, China.
Department of Anesthesiology, Suqian Maternity and Children's Hospital Suqian 223800, Jiangsu, China.
Am J Transl Res. 2024 May 15;16(5):1953-1961. doi: 10.62347/UTAB1666. eCollection 2024.
To examine the impact of using intraoperative cell salvage (ICS) for the restoration of coagulation function in cases of massive Post-Cesarean Section Hemorrhage (PCSH).
A retrospective analysis was conducted on 60 cases of massive PCSH meeting inclusion criteria at Suqian Maternity and Children's Hospital from January 2020 to July 2022. Patients were divided into two groups: allogeneic blood transfusion group (Group A, n = 30) and ICS group (Group B, n = 30), based on transfusion methods. Blood parameters, coagulation function, and adverse reactions were assessed before (T0) and after (T1) transfusion. Patients were categorized into good prognosis (GP) and poor prognosis (PP) groups based on adverse reaction occurrence. Clinical profiles were compared between groups, and multivariate binary logistic regression analysis was employed to evaluate the factors that may affect the prognosis in women with PCSH.
No significant differences in routine blood parameters were observed between groups at T0 and T1 (P>0.05). At T0, no significant differences in PT, APTT, TT, or FIB were found between groups (P>0.05). Both groups showed a reduction in PT, APTT, and TT values at T1 compared to T0, with Group B experiencing a more significant decrease than Group A (P<0.05). FIB increased in both groups at T1 compared to T0, with Group B demonstrating a higher increase than Group A (P<0.05). Both groups showed increased blood pressure at T1 compared to T0, with Group B showing a more pronounced elevation than Group A (P<0.05). The occurrence of adverse reactions was significantly lower in Group B (1/30, 3.33%) compared to Group A (7/30, 23.33%) (P<0.05). Logistic regression analysis identified FIB<1.52 g/L and HR<45.35 times/min as factors associated with increased risk of unfavorable outcome in women with PCSH.
In patients experiencing significant PCSH, ICS may lead to better postoperative recovery of blood parameters, faster restoration of coagulation function, and reduced risk of adverse events compared to ABT. Moreover, early detection of coagulation function and blood gas indexes is crucial for clinicians to implement timely prevention and treatment measures.
探讨术中自体血回输(ICS)对剖宫产术后大出血(PCSH)患者凝血功能恢复的影响。
对2020年1月至2022年7月在宿迁市妇幼保健院符合纳入标准的60例PCSH患者进行回顾性分析。根据输血方式将患者分为两组:异体输血组(A组,n = 30)和ICS组(B组,n = 30)。在输血前(T0)和输血后(T1)评估血液参数、凝血功能及不良反应。根据不良反应发生情况将患者分为预后良好(GP)组和预后不良(PP)组。比较两组的临床资料,并采用多因素二元logistic回归分析评估可能影响PCSH患者预后的因素。
两组在T0和T1时的血常规参数无显著差异(P>0.05)。在T0时,两组的PT、APTT、TT或FIB无显著差异(P>0.05)。与T0相比,两组在T1时PT、APTT和TT值均降低,B组降低更显著(P<0.05)。与T0相比,两组在T1时FIB均升高,B组升高更明显(P<0.05)。与T0相比,两组在T1时血压均升高,B组升高更显著(P<0.05)。B组不良反应发生率(1/30,3.33%)显著低于A组(7/30,23.33%)(P<0.05)。logistic回归分析确定FIB<1.52 g/L和HR<45.35次/分为与PCSH患者不良结局风险增加相关的因素。
对于发生严重PCSH的患者,与异体输血相比,ICS可能导致术后血液参数恢复更好、凝血功能恢复更快且不良事件风险降低。此外,早期检测凝血功能和血气指标对于临床医生及时实施预防和治疗措施至关重要。